"You know."
Hearing this tone, Kingsley Weir immediately understood.
The director of the European Medicines Agency was asking him for money.
Of course, this kind of statement is a bit too straightforward, so to put it nicely, this is called political donation.
Any drug that can be put on the market can bring huge profits, let alone thrombolytic drugs. The annual market size of this type of drug alone is huge.
Coupled with the powerful effect of RSCA, it can be said that once it enters the market, it will definitely be favored by major doctors.
Of course, it is precisely for this reason that those board members who have the power to market drugs naturally have a stable source of income.
Kingsley Weir knew this situation all too well.
After all, he has dealt with these people before. He was once an associate professor at the Federal Institute of Technology in Zurich. When he was a consultant for some pharmaceutical companies, he attended relevant meetings before listing as an expert and communicated with these people.
All in all, whether a new drug can be officially launched on the market, in addition to passing clinical trials, it must also be approved by these people.
Of course, these things will only happen after several phases of clinical trials have been completed and there is no problem with the listing qualifications. Kingsley Weir has already made psychological preparations. At that time, the listing is already in sight, and it is acceptable to spend some money.
But what he never expected was that now that their clinical trials have not been approved, these people would come and ask for money?
Isn’t this bullying an honest person?
He suppressed the anger in his heart and said in a deep voice: "Mr. Gerry, now we haven't even approved the clinical trial application. Isn't this a bit against the rules?"
The person on the other end of the phone scoffed.
"Rules? Whether the talisman conforms to the rules or not is not your decision."
"Oh, forget it." As he spoke, Director Gerry suddenly sighed again, and finally said: "I won't waste my time with you. I wish you good luck."
Then the call was hung up directly, leaving Kingsley Weir confused.
What does the last sentence that the other party suddenly said mean?
waste time?
Wish them good luck?
I put down my cell phone, got up and walked around, thinking.
But in the end he couldn't think of anything.
"Forget it, let's call the boss first..."
His expression became worried. Even the clinical application could not be approved, and the market launch was even further away.
No matter how effective their new drug is, as long as it cannot pass such a process, it will never enter the market.
But just when he was about to make a call, there was a knock on the office door.
He was stunned for a moment and looked out the door.
The office was rented recently and is very small. After all, there are not many people in their company now. At most, there is only one receptionist. And his office is just a small cubicle with transparent glass doors. .
So he could see standing outside the door the company's receptionist and a man in formal clothes.
Guess it was that man who wanted to see him?
"Please come in."
He spoke.
Then the receptionist opened the door and let the man walk in.
"Hello, Mr. Weir, please introduce yourself, Bayer Company, Winston Gervin."
After the man walked in, he smiled and said.
Kingsley Weir was stunned for a moment.
Bayer?
Bayer is a well-known pharmaceutical company in Germany and is well-known around the world.
But the question is why did this company suddenly come to him?
Weir stepped forward and shook his hand politely.
"Hello, Mr. Gervin, how come the mighty Bayer Company cares about our small company?"
"Small company?" Winston Gervin raised his eyebrows, and then said with a smile: "Your company is not a small company. After all, your boss is the most talented person in the world."
"Perhaps for all technology companies, you should be fortunate that your boss has not entered the field of technology companies so far, otherwise it may directly lead to changes in the entire pattern."
"Haha, with our boss's ability, I have no doubt about it."
Kingsley Weir smiled indifferently. Having been with Li Mu for so long, he knew very well how powerful this boss was, so he would not question this issue.
Winston Gwen laughed and shook his head, and then said: "But it is a pity that such a talent cannot make him completely comfortable in society."
While Kingsley Weir was frowning in confusion, Winston Gervin directly revealed the answer: "If I guess correctly, your RSCA clinical application has not been approved by the EMA, is it?"
Kingsley Weir was stunned for a moment and said in surprise: "How do you know?"
The information he just got from the EMA director, does Bayer know now?
He immediately realized that there were some ulterior things hidden in it.
Then, Winston Gervin said with a smile: "Your RSCA is in very direct competition with Pfizer's PEFF. Think about it, can Pfizer easily allow you to conduct clinical trials?"
"If the information we got is correct, the main reason why they rejected your clinical trial is because you are."
"You are the main researcher of RSCA, and you almost caused a leak in the first place, so it is within the EMA's discretion to reject your application."
Listening to Winston Gervin's words, Kingsley Weir suddenly recalled the phone call he had just had with Director Gerry...
That Gerry obviously had no intention of helping them get approval. In the end, he asked for political donations. He probably just wanted to cheat them. However, when they still failed to get approval, he only needed to say "I have tried hard to persuade him." The other directors said, "but they still don't agree" and dismissed the matter.
His expression suddenly became angry, but after the anger, there was a kind of powerlessness.
After all, that's Pfizer...
But at this moment, Winston Gervin noticed the change in Kingsley Ware's expression, and then said with a smile: "What? You want to give up because it's Pfizer?"
"Mr. Weir, let me tell you the truth. I am here on behalf of Bayer just to help you solve this matter."
"The conditions are also very simple. You will license the RSCA patent to Bayer, and Bayer will activate our relationship to help launch RSCA."
"Although Pfizer is indeed very powerful, here in Europe, Bayer is also worthy of your trust."
"As long as it is approved by the EMA, it will be relatively easy to get approved by the FDA. What's more, we also have people at the FDA."
"How about it? Do you want to think about it?"
Winston Gervin smiled.
"And don't worry, we won't disappoint you in terms of conditions."
"As long as the results of RSCA do not disappoint, and it finally passes the third phase of clinical trials and is launched on the market, we will be responsible for all related marketing work, and you can get 15% of the profit."
"One and a half percent?"
Kingsley Weir was a little surprised when he heard the conditions given by the other party. One and a half percent was indeed not low, especially now that the other party had taken over all the pre-IPO work, which naturally included dealing with the politicians. Jobs, these are things that new companies cannot do anyway.
In addition, there is the establishment of production plants and subsequent sales channels. In these aspects, Bayer, which is not much smaller than Pfizer, has all of them.
Of course, he quickly understood why the other party was able to offer such conditions.
Although Bayer is also a world-famous pharmaceutical company, it is relatively weak in the pharmaceutical field. Obviously, they now also hope to get a share of the pharmaceutical pie.
(End of chapter)
